FreeAgent 2ce99ef787edaae96046afb3fbfaf10fd19127ee false No description of principal activity 27 August 2024 31 January 2026 159190082024-08-272026-01-31 15919008uk-bus:Director12024-08-272026-01-31 15919008uk-bus:AuditExempt-NoAccountantsReport2024-08-272026-01-31 15919008uk-bus:Micro-entities2024-08-272026-01-31 15919008uk-bus:FullAccounts2024-08-272026-01-31 15919008uk-bus:PrivateLimitedCompanyLtd2024-08-272026-01-31 15919008uk-bus:RegisteredOfficeuk-countries:UnitedKingdom2024-08-272026-01-31 159190082024-08-27 159190082026-01-31 15919008uk-core:CurrentFinancialInstruments2026-01-31 15919008uk-core:Non-currentFinancialInstruments2026-01-31 iso4217:GBP xbrli:pure

LONDON CENTRE FOR ENDOCRINOLOGY & DIABETES LTD

Unaudited financial statements for the period from 27 August 2024 to 31 January 2026


Company information

LONDON CENTRE FOR ENDOCRINOLOGY & DIABETES LTD is a private company limited by shares, registered in England and Wales, registered number 15919008.

The company's registered office is: 24 Imber Close, Esher, kt10 8eb, United Kingdom.

Balance Sheet

as at 31 January 2026

17 months to
31 Jan 26
£ £
Current assets 8,715.67
Creditors: amounts falling due within one year (4,885.64)
Net current assets / (liabilities) 3,830.03
Total assets less current liabilities 3,830.03
Accruals and deferred income (500.00)
Net assets 3,330.03
Capital and reserves 3,330.03

For the period from 27 August 2024 to 31 January 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Directors' responsibilities:

Approved by the board of directors and signed on behalf of the board,

Vanitha Karunakaran
18 August 2026

Notes to the accounts

  1. Average number of employees

    During the period the average number of employees was 0.